Shaping the Future of Vision Care: Europe Ophthalmology Drugs and Devices Market Outlook
Europe ophthalmology drugs and devices market is expected to witness market growth at a rate of 5.95% in the forecast period of 2022 to 2029, and is estimated to reach the value of USD 15.50 billion by 2029.
The Europe ophthalmology drugs and devices market represents one of the most dynamic segments in the healthcare industry, driven by a growing aging population, rising prevalence of vision disorders, advancements in medical technology, and heightened awareness about eye health. Ophthalmology encompasses the diagnosis, treatment, and prevention of eye diseases, with drugs and devices forming the backbone of treatment regimens across the region.
The increasing incidence of conditions such as cataracts, glaucoma, age-related macular degeneration (AMD), diabetic retinopathy, and refractive errors is generating consistent demand for both pharmacological solutions and surgical or diagnostic devices.
Europe is recognized as a mature market for healthcare innovation, with a robust pharmaceutical sector and advanced healthcare infrastructure.…